Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...

"We have a mycobacterial drug that works for nontuberculous mycobacteria and M. tuberculosis that is biological, not phage therapy, and not small molecule antibiotics," said Jason Holder ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with 'kill switches' that can be triggered to stop the bacteria after they activate ...

They found that mycobacteria: are more prevalent in the United States than in Europe; thrive more in municipal tap water than in well water; are more abundant in metal showerheads than in plastic ones ...

Michael S. Glickman, MD Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria, including the use of mycobacteria as bacterial cancer therapies.

Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two ...